Price Ceiling, Compulsory licensing of patented medicines Necessary: Govt panel Medical Dialogues Bureau28 Jan 2019 12:50 PM ISTWorried about "high prices" and "unaffordability" of patented medicines in India, the Department of Pharmaceuticals (DOP) formed this...
US court upholds dismissal of 200 million dollars Merck verdict against Gilead Ruby Khatun Khatun27 April 2018 9:30 AM ISTA U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
Roche sues Pfizer to bar biosimilar of cancer drug Herceptin Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTRoche Holding AG, facing pressure in Europe as cheaper biosimilars of its three biggest cancer medicines chew away at its revenue, sued to block...
Suven Life Sciences gets patents from India, US, Hong Kong on neurological molecule Ruby Khatun Khatun17 Nov 2017 10:00 AM ISTNew Delhi: Suven Life Sciences said it has been granted a patent each from Hong Kong and the US and two from India for treatment of disorders...
US House committee launches probe of Allergan patent deal Ruby Khatun Khatun6 Oct 2017 9:00 AM ISTNEW YORK: A U.S. House of Representatives committee launched a probe into drugmaker Allergan Plc's deal to transfer some of its patents to a Native...
US judge invalidates Mallinckrodt patents on respiratory treatment Ruby Khatun Khatun7 Sept 2017 9:47 AM ISTA federal judge in Delaware on Tuesday invalidated patents held by Mallinckrodt Pharmaceuticals on its Inomax respiratory treatment system.The ruling...
